BRITISH SOCIETY FOR HAEMATOLOGY
63rd Annual Scientific Meeting of the British Society for Haematology23 - 25 April 2023, Birmingham
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| EP-002 | Prostaglandin G/H Synthase Signalling promotes Poor Outcome and Chemoresistance in Acute Myeloid Leukaemia | Abdullah Alshammari |  Received |
 |
|||
| EP-006 | Prognostic Value of Indicators of Neoplastic Inflammation in the Patients with Acute Leukemia | Vira Barilka | Received |
|
|||
| EP-007 | A Single Centre Experience of Using Venetoclax and Azacitidine in the Treatment of AML | Emily Booth | Received |
|
|||
| EP-008 | Comparison of myeloblast cell percentage in investigations diagnosing Acute Myeloid Leukaemia | Naml Iftikhar | Received |
|
|||
| EP-009 | Induction mortality rate in eldery AML patients treated with Venetoclax/Azacitidine compared to standard induction chemotherapy. | Israa Kaddam | Received |
|
|||
| EP-010 | HUMAN PAPILLOMAVIRUS VACCINATION FOR FANCONI ANEMIA PATIENTS | eman khattab | Received |
|
|||
| EP-011 | Vyxeos for Secondary AML in the West of Scotland: A Real World Experience | James Leveson | Received |
|
|||
| EP-012 | QIP leading to a significant improvement in antibiotic outcomes in neutropenic patients with Haematological malignancies | Arina Madan | Received |
|
|||
| EP-013 | UK Healthcare Professional Experiences with Intensive Chemotherapies for AML: Survey of Tolerability and Ambulatory Delivery | Georgia Batchelor | Received |
|
|||
| EP-014 | UK Experience with Ambulatory Delivery, Hospitalisation Time and Safety of CPX-351 in Patients with AML | Georgia Batchelor | Received |
|
|||
| EP-015 | Assessing fever-to-needle times in neutropenic patients at a tertiary haemato-oncology centre | Annabelle Chung | Received |
|
|||
| PO-015 | The Journey to e-Referrals in Haematology: A Local Experience of Implementation at a Tertiary Centre | Jamila Bashir | Received |
|
|||
| EP-017 | Phase 2 Randomised Trial, Repurposing Danazol and VBaP in Low Risk Myelodysplastic Syndrome: REPAIR MDS | Manoj Raghavan | Received |
|
|||
| EP-021 | PeRsOnalised PrEhabilitation in people with acute myeloid Leukaemia; development of the PROPEL trial. | Simon Stanworth | Received |
|
|||
| PO-022 | Can Patients Meaningfully Contribute to Genomics Research? | Noemi Roy | Received |
|
|||
| EP-023 | Cytogenetic Profile of Acute Lymphoblastic Leukemia Patients and its Association with Induction Remission Status | Umarah Khan | Received |
|
|||
| EP-024 | Factors affecting the Haematopoetic stem cell engraftment in a cancer centre in South India | ARUN V J | Received |
|
|||
| EP-025 | Presenting features and long-term outcomes of paediatric patients with ALL who developed severe vincristine-induced neuropathy | Hannah Giles | Received |
|
|||
| EP-027 | A Curious Case Of Acute Lymphoblastic Leukemia With Intractable Hepatic Dysfunction: Progressive Familial Intrahepatic Cholestasis | Vagisha Sharma | Received |
|
|||
| EP-028 | Improving Laboratory Haematology Training: Developing an Educational Resource for Haematology Trainees in the West Midlands | Lorna Cain | Received |
|
|||
| EP-029 | Using Creative Methods to Enable Reflection in Haematology Teaching | Stephen Hibbs | Received |
|
|||
| EP-030 | Solving Problems and Creating Others: Five Years of Trainee-Led Educational Innovation | Stephen Hibbs | Received |
|
|||
| PO-030 | Increasing blood cancer awareness and confidence in managing patient care through online education | Khadijha Sundus | Received |
|
|||
| EP-031 | Bridging the Gap Between Patients and Clinical Trials - the End of a 3-Year Pilot | Jane Nunnick | Received |
|
|||
| EP-032 | Clinical Trials Support Service, Less Clinical Trials, More Support? | Jane Nunnick | Received |
|
|||
| EP-033 | Development of a collaborative multidisciplinary working model for a cohort of Haematology patients | Nicola Ransome | Received |
|
|||
| EP-034 | The OnControl Powered Bone Marrow: An Audit of Patient Outcomes for 79 Patients in Birmingham | Hisam Siddiqi | Received |
|
|||
| PO-034 | Ruxolitinib and Magrolimab Significantly Increases Calreticulin Expression in Myelofibrosis. Proof of Concept for Combination Therapy | Ciro Rinaldi | Received |
|
|||
| EP-035 | A Multi-modal Integrated Approach for Introducing Trainees to Blood Film Morphology | OLGA TSIAMITA | Received |
|
|||
| EP-036 | Dental pathway for patients undergoing bone marrow transplant- a service evaluation | Rakhee Budhdeo | Received |
|
|||
| EP-037 | Self-management practices in patients with a haematological malignancy: a mixed methods study. | Kirsty Crozier | Received |
|
|||
| EP-038 | Evolution of an Acute Leukaemia Nurses Group | Kirsty Crozier | Received |
|
|||
| EP-039 | Introducing an E-Game Resource to Evaluate Haemoglobinopathies Teaching in the UK and Malawi | Diana De | Received |
|
|||
| PO-039 | Evusheld Prophylaxis increases Social Interactions and improves Anxiety, Depression, Agoraphobia and Quality of Life scores in blood cancer patients | Annabel Follows | Received |
|
|||
| EP-041 | The evolution of a charity Support Services Team | Gemma Trout | Received |
|
|||
| EP-042 | Developing Nurse Researchers - Experiences from a tertiary referral centre in Wales. | Emma Williams | Received |
|
|||
| EP-043 | Ropeginterferon alfa-2b as an option in managing high-risk pregnancy in Essential Thrombocythaemia and Polycythaemia Vera | LLywelyn Cadman-Davies | Received |
|
|||
| EP-044 | The Efficacy of Rituximab in Patients with Chronic Immune Thrombocytopenic Purpura. A Single Centre Experience. | Sarah Davis | Received |
|
|||
| EP-046 | Clinical Results From Immediate Ruxolitinib to Momelotinib Transition in Patients With Myelofibrosis | Mamta Garg | Received |
|
|||
| PO-046 | United Kingdom Retrospective Observational Study of Romiplostim and Other Treatments in Early Immune Thrombocytopenia | lorraine stephens | Received |
|
|||
| PO-047 | Comparative Effectiveness of Fostamatinib vs. Rituximab in Refractory Chronic Immune Thrombocytopenia: a Network Meta-Analysis | David Gomez Ulloa | Received |
|
|||
| PO-048 | Efficacy and Safety of Erythropoiesis Stimulating Agents (ESAs) in Myelofibrosis- A Single Centre Experience. | Amany Ihab Mohamed | Received |
|
|||
| EP-048 | Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis: Results of a Long Term UK Prospective Cohort Study | Rupen Hargreaves | Received |
|
|||
| EP-049 | Pooled Long-Term Safety Data From 3 Phase 3 Randomized-Controlled Trials (RCTs) of Momelotinib (MMB) | Claire Harrison | Received |
|
|||
| EP-050 | Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients with Myelofibrosis and Thrombocytopenia | Claire Harrison | Received |
|
|||
| PO-050 | A single-centre retrospective analysis comparing the prognostic utility of the risk-stratification tools used in Myelofibrosis | Mohamed Omer | Received |
|
|||
| PO-051 | The role of Next Generation Sequencing in Myeloproliferative Neoplasms associated with Splanchnic Vein Thromboses (MPN-SVT) | Iman ORiordan | Received |
|
|||
| EP-051 | COVID-19 Pre-exposure Prophylaxis With Tixagevimab/Cilgavimab In Patients With Hematologic Malignancy: A Single Center Experience | Kee Tat Lee | Received |
|
|||
| EP-052 | Prevalence and Causes of Megaloblastic Anemia in South India | Sasmith Menakuru | Received |
|
|||
| EP-53 | Does Macrocytic Anemia Have A Correlation With The Severity Of Cirrhosis? | Menakuru Sasmith | Received |
|
|||
| PO-053 | An Audit of Paroxysmal Nocturnal Haemoglobinuria (PNH) requesting at University Hospitals of North Midlands | Jayasekara Prasangika | Received |
|
|||
| EP-054 | Aggregate Index of Systemic Inflammation and systemic inflammation response index: novel diagnostic biomarkers in Preeclampsia. | Theresa Nwagha | Received |
|
|||
| PO-055 | Thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. From UK adult ITP registry. | Vickie Mcdonald | Received |
|
|||
| EP-055 | MPN Patient Symptom Recognition: Results from the MINUTES Survey | Emma-Louise Tarburn | Received |
|
|||
| PO-056 | What Does Existing Data Tell Us About Care Experiences of Minority Ethnic Blood Cancer Patients? | Emma Caton | Received |
|
|||
| EP-056 | Lack of Correlation Between Bone Marrow Fibrosis and Efficacy of Momelotinib or Ruxolitinib in Myelofibrosis | Frances Wadelin | Received |
|
|||
| EP-057 | Management of life threatening refractory immune thrombocytopenia purpura in pregnancy and the peripartum period: | Shaista Zubair | Received |
|
|||
| EP-058 | Mycobacterium Chelonae Mimicking Erythema Nodosum Progressing to Catheter Tract Infection in a Child with Leukaemia | Ranjan Tiwari | Received |
|
|||
| PO-059 | Rates of Hospital Admission and Mortality in Patients with MGUS and COVID-19 Infection. | Ying Qi Yeo | Received |
|
|||
| EP-061 | Promoting Consultant Clinical Scientist roles in Haematology and Transfusion | Shubha Allard | Received |
|
|||
| EP-062 | Hyperhaemolysis - secondary to clostridium perfringens in a patient treated for DLBCL. | Angela Clarke | Received |
|
|||
| EP-064 | Single Unit Blood Transfusion- how are we doing? | Joanna Han Yen Ting | Received |
|
|||
| EP-065 | Evaluation of the cryotherapy effect on blast injuries by haematological indexes. | Inesa Iefimova | Received |
|
|||
| EP-066 | Donor deferral patterns among voluntary blood donors in Regional Blood Centre Batticaloa. | Gauri Jayasinghe | Received |
|
|||
| EP-067 | Characteristics of voluntary blood donors in Regional Blood Centre Batticaloa SriLanka. | Gauri Jayasinghe | Received |
|
|||
| EP-068 | Lupus anticoagulant screening: Is it done appropriately? | Ahmed Amer | Received |
|
|||
| EP-069 | A Dual Centre Retrospective Study of Prothrombin Complex Concentrate Usage | Michelle Melly | Received |
|
|||
| EP-071 | Outcome of Haematological Indices in Hospitalized Yellow Fever Patients at Federal Medical Centre, Asaba, Nigeria | Sylvia Ifeoma Obu | Received |
|
|||
| EP-072 | Analysis on the Management of Anaemia and Red cell Transfusion Thresholds in Critically ill patients | Lakeesha Piyasundara | Received |
|
|||
| EP-073 | ANAPHYLACTIC SHOCK TO A HEMATOLOGICAL DISORDER PATIENT DURING TRANSFUSION OF PLATELET-APHERESIS UNIT IN ADDITIVE SOLUTION | Bala Bhasker Poluru Mranikrinda | Received |
|
|||
| EP-074 | Recommended Cell Markers in Lymphoproliferative Diagnosis: A Delphi Poll. | Iman Qureshi | Received |
|
|||
| EP-075 | The utility of extended haematology red cell parameters for the prediction of birth outcomes. | Nicola Ransome | Received |
|
|||
| EP-079 | Prevalence of Alloimmunization among Haematology patients on chronic transfusion program attending SUH | Jimmy William | Received |
|
|||
| EP-080 | Blood tube shortages 2021: did guidance limiting usage result in reductions: a single-centre pilot audit | Lydia Wilson | Received |
|
|||
| EP-81 | Intrahepatic Cholestasis in Paediatrics Sickle Cell Disease: Two Cases from Oman | Wafa Al Sarkhi | Received |
|
|||
| EP-082 | Seroprevalence of SARS-CoV-2 in children of school-going age in District Swabi ,Pakistan | Muhammad Arif | Received |
|
|||
| EP-083 | Hypercoagulable State in Children with a-thalassemia disease and -thalassemia/haemoglobin E: Role of ROTEM and Microparticles | Chane Choed-Amphai | Received |
|
|||
| EP-084 | Therapeutic Plasma Exchange in managing Optic Neuritis in a pediatric patient. | Gauri Jayasinghe | Received |
|
|||
| EP-088 | Maintenance Rituximab in Follicular Lymphoma - A Single Centre Experience | Francis Anyanwu | Received |
|
|||
| EP-089 | Treatment Outcomes in Older Patients with Systemic Diffuse Large B-cell Lymphoma | Caragh Brien | Received |
|
|||
| PO-089 | Relationship between Skin, Blood and Lymph Node Responses in Mogamulizumab-treated Patients: MAVORIC Trial Post-hoc Analysis | Lay Ean Tan | Received |
|
|||
| EP-090 | Should age influence treatment options in elderly patients with diffuse large B-cell lymphoma? | Cameron Clark | Received |
|
|||
| EP-091 | Pathological Fracture as a Presenting Feature in Non-Hodgkins Lymphoma: A Scoping Review | Emily Davenport | Received |
|
|||
| EP-093 | Ruxolitinib in Adult Primary Hemophagocytic Lymphohistiocytosis | Betty Gration | Received |
|
|||
| EP-095 | Black pepper oil and D-Limonene inhibit growth and induce apoptosis in Mantle Cell Lymphoma | Marwa Jbara | Received |
|
|||
| EP-096 | A tertiary centre experience in using Trametinib (MEK-1 inhibitor) in multi-system Langerhans cell Histiocytosis in Scotland | Wei Lynn Khor | Received |
|
|||
| EP-098 | Is CMV Reactivation a Trouble in Non-Allogenic Transplant Cancer Patients? An Experience of Single Institute | Uzma Rasool Mahar | Received |
|
|||
| EP-099 | Two week wait referrals for patients without cancer. How much of a burden is it? | Thomas Mayo | Received |
|
|||
| EP-100 | A Retrospective Observational Study of CAR T cell therapies Outcomes- Experience from MSE Foundation Trust | Chinonye Onyeocha | Received |
|
|||
| PO-100 | Experiences of Flying in Patients With Sickle Cell Disease (SCD): A Service Evaluation Project | Thomas Glynn | Received |
|
|||
| EP-101 | Classical Hodgkin Lymphoma: Circulating Natural Killer Cell Subsets in an HIV Endemic Setting. | Jessica Opie | Received |
|
|||
| EP-102 | Modelling Acquired Resistance to Vorinostat in Sézary Syndrome Cells | Navin Kumar Verma | Received |
|
|||
| EP-103 | CD37 and ICOSLG expression in diffuse large B cell lymphoma (DLBCL). | Dominika Lubawska | Received |
|
|||
| PO-105 | Determinants of Splenic Preservation among Patients with Sickle Cell Disease in North-Eastern Nigeria | Adama Isah Ladu | Received |
|
|||
| EP-106 | Managing Severe Warm Autoimmune Haemolytic Anaemia after the SARS-Cov-2 Vaccine with Emergency Splenectomy and Eculizumab. | Emma Jackson | Received |
|
|||
| EP-107 | Clinical and Laboratory Factors Associated with Splenic Dysfunction Among Sickle Cell Disease Patients | Adama Isah Ladu | Received |
|
|||
| EP-108 | Evaluation of Red cell Inclusions for Assessing Spleen Function Among Sickle Cell Disease Patients | Adama Isah Ladu | Received |
|
|||
| PO-109 | Using wearables and web-based self-reporting to explore deep-sleep and patient-reported-outcome correlations in sickle cell disease. | Kim Summers | Received |
|
|||
| EP-109 | The Use of Fibroscans in Patients with Genetic Haemochromatosis at Diagnosis- a Single-centre Audit | Devi Purushothaman | Received |
|
|||
| EP-111 | Evaluation of serum albumin and trace elements in children with sickle cell disease | Olivier Mukuku | Received |
|
|||
| PO-111 | Mode of Nipocalimab Action and Pharmacology in Cells and Preclinical Models | Prasanthi Chengalva | Received |
|
|||
| EP-112 | Association of Platelet Integrin aIIb3 Polymorphisms with Atherosclerotic Coronary Heart Disease in Sudanese Patients | Lamyaa Ali | Received |
|
|||
| PO-112 | Designing ENERGY: A Phase 2/3 Study of Nipocalimab in Warm Autoimmune Hemolytic Anemia | Ubedul Hoda | Received |
|
|||
| EP-113 | A PNH case presenting with stent thrombosis and review of haematological presentations with stent thrombosis | Rachael Biggart | Received |
|
|||
| EP-114 | Not All Pregnancies are greeted with a Sweet Aftercourse- Thrombotic Microangiopathies in Pregnancy | Mehndi Dandwani | Received |
|
|||
| EP-115 | Management of a Thrombotic Microangiopathy Associated with EBV and CMV Infection in an ICU | El Amani Maha | Received |
|
|||
| EP-116 | Successful liquid warfarin therapy in a patient with Short Bowel Syndrome | Angela Theodoulou | Received |
|
|||
| EP-117 | High-normal renal function effect on apixaban levels for venous thromboembolism treatment in obese patients. | Raza Alikhan | Received |
|
|||
| EP-118 | Identifying Causal Variants in Young Patients with Unprovoked Thrombosis | Ammar Hilali | Received |
|
|||
| EP-119 | Summary of Use: Andexanet in Greater Glasgow and Clyde Health Board. | Laura Knox | Received |
|
|||
| EP-120 | An Audit of Heritable Thrombophilia Testing in a District General Hospital | Hui Wen Liang | Received |
|
|||
| EP-121 | QIP leading to significant improvement in DNAR-form completion for COVID-19 patients on Intensive Care | Arina Madan | Received |
|
|||
| EP-123 | A case series of Cyclophosphamide Usage in Refractory Immune Thrombotic Thrombocytopaenic Purpura (TTP). | Michelle Melly | Received |
|
|||
| EP-124 | Is there a risk of inhibitor recurrence whilst on emicizumab prophylaxis with intron 22 mutations? | Benjamin Miguras | Received |
|
|||
| EP-126 | Clinical Concordance of Radiometer AQT90 Flex Point of Care D-dimer Measurement versus Two Laboratory Methods | Bethan Phillips | Received |
|
|||
| EP-127 | Case Report of Pulmonary Embolism in a patient with Thrombotic Thrombocytopenic Purpura after Plasmapheresis | Gyuhee Seong | Received |
|
|||
| EP-128 | Integrating Psychology Services into TTP Patient Care: A Specialist Centre Experience | Rebecca J Shaw | Received |
|
|||
| EP-129 | Use of extended half-life FVIII for elective surgical procedures: a tertiary centre experience | Conor Feely | Received |
|
|||
| EP-130 | A case series of the use of Andexanet in Leeds Teaching Hospitals | Mevish Ul-haq | Received |
|
|||
| EP-132 | Incidence of Venous Thromboembolism at the Diagnosis of Diffuse Large B Cell Lymphoma | Wan Awatif Wan Mohd Zohdi | Received |
|
|||
| PO-132 | Interim results of the LEAP Pilot: Low Molecular Weight hEparin vs. Aspirin Postpartum | Evangelia Vlachodimitropoulou | Received |
|
|||
| PO-134 | Single Centre Experience on Long Term Safety and Efficacy of Emicizumab in Paediatric Patients | Eman Hassan | Received |
|
|||
| EP-134 | ROTEM and Clot Waveform Analysis as A Point-of-care Tests for Diagnosis of Disseminated Intravascular Coagulation in Critically-ill Children in Thailand | Supapitch Chanthong | Received |
|
|||
| EP-135 | Safety and Efficacy of Rivaroxaban for paediatric Cancer-AssociatedTthrombosis- Single Centre Experience | Ranjan Tiwari | Received |
|
|||
| EP-136 | Real world adverse event data for a secondary care led DOAC review process | Sarah Bond | Received |
|
|||
| EP-137 | Venous Thrombosis events associated with Thoracic Surgery in a Teaching Hospital: 2012 - 2022 | Huw Rowswell | Received |
|
|||
| EP-138 | The Effect of ABO Incompatibility on the Outcome of Stem Cell Transplant | Natasha Ali | Received |
|
|||
| PO-138 | MajesTEC-4: Phase 3 Trial of TeclistamabLenalidomide Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma | Daniel Zaldumbide | Received |
|
|||
| EP-139 | Kaposi Sarcoma Following Chimeric Antigen Receptor T-cell Therapy. | Patricia Banda | Received |
|
|||
| EP-140 | Haematologic Toxicity and Blood Product Transfusion Requirements during Autologous Stem Cell Transplant for Myeloma | Ellouise Bishop | Received |
|
|||
| EP-141 | Experiences of Patients from Minority Ethnic Backgrounds in the Stem Cell Transplant Pathway During COVID-19 | Emma Caton | Received |
|
|||
| EP-142 | Educational Requirements in the United Kingdoms CAR-T Ecosystem | Maria Garcia Gomez | Received |
|
|||
| EP-143 | Comparing Antigen Expression in Adult and Paediatric Acute Myeloid Leukaemia: a Systematic Literature Review | Hanya Ghazi | Received |
|
|||
| EP-144 | GvHD Pathological Grade Predicts Overall Survival | Edward Osmond | Received |
|
|||
| EP-145 | Haematology Ambulatory Transplant in a District General Hospital Setting Results Of Pilot Study | Debora Almeida | Received |
|
|||
| EP-146 | Empowering myeloma patients regimen control and comprehension via the use of chemotherapy compliance aids | Sandhya Abraham | Received |
|
|||
| EP-147 | Treatment Outcome of Newly Diagnosed Multiple Myeloma at the National Center of Hematology in Iraq | Abdulsalam Al-Ani | Received |
|
|||
| PO-148 | Response rates to second line treatment with Daratumumab Bortezomib Dexamethasone (DVD) in relapsed/refractory AL amyloidosis | Joshua Bomsztyk | Received |
|
|||
| EP-148 | Paraneoplastic Sarcoidosis In Multiple Myeloma . | Muzna Aquil | Received |
|
|||
| EP-149 | A Single Centre 7-year Experience of Bleeding Events In CLL Patients taking Ibrutinib and Anticoagulation | Varvara Bashkirova | Received |
|
|||
| EP-150 | Multiple myeloma revealed by sphenoid plasmacytoma | Sarra Chadli | Received |
|
|||
| EP-151 | Retrospective Review of Vaccination Status in Patients with Newly Diagnosed Chronic Lymphocytic Leukaemia | Samantha Drummond | Received |
|
|||
| EP-152 | Patient Experience in Relapsed/Refractory Chronic Lymphocytic Leukaemia UK Clinical Practice: Study Methodology Overview | Dima El Sharkawi | Received |
|
|||
| PO-153 | Monoclonal Gammopathy of Renal Significance: Are We Investigating Possible Cases Appropriately? A Quality Improvement Project. | Lisa Jeffers | Received |
|
|||
| EP-154 | Real world experience of the burden of infection in myeloma | Richard Hinton | Received |
|
|||
| PO-155 | Impact of Baseline Ocular Conditions on Belantamab Mafodotin-Related Corneal Events in Relapsed/Refractory Multiple Myeloma | Katelyn Kim | Received |
|
|||
| EP-155 | Monoclonal immunoglobulin deposition disease successfully diagnosed by laser microdissection-liquid chromatography-tandem mass spectrometry | Seiji Kakiuchi | Received |
|
|||
| EP-156 | ReVenG: A Phase 2 Study of Venetoclax plus Obinutuzumab Retreatment in Relapsed Chronic Lymphocytic Leukemia | Joanne Kelly | Received |
|
|||
| EP-157 | An audit of compliance with BCSH guidelines for investigation of M-proteins and management of MGUS. | Emily Kerr | Received |
|
|||
| PO-158 | Retrospective multi-centre study comparing survival outcomes in Chronic Lymphocytic Leukaemia (CLL) with genetic risk stratification. | Iman Qureshi | Received |
|
|||
| EP-158 | Introduction to the Role of the Myeloma Physiotherapist at Hampshire Hospitals NHS Foundation Trust (HHFT). | Emily Mean | Received |
|
|||
| PO-159 | Single-Agent Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Final Analysis of the DREAMM-2 Trial | Katelyn Kim | Received |
|
|||
| EP-159 | Outcomes from real world use of Belantamab Mafodotin at the Beatson West Of Scotland Cancer Centre (BWOSCC) in multiply relapsed/refractory myeloma patients | mairi walker | Received |
|
|||
| EP-160 | Tackling delayed Diagnosis in Myeloma: The Laboratory Best Practice Tool | Fenella Willis | Received |
|
|||
| PO-161 | Management of Cardiovascular Complications of BTKis: Are we Complying with the Good Practice Guidelines? | Nikita Sarania | Received |
|
|||
| PO-162 | Evaluating the Incidence and Outcomes of Myeloma Diagnosed via Emergency Presentations in Cardiff and Vale Health Board | Angharad Treharne-Jones | Received |
|
|||
| EP-162 | EMagine/CARTITUDE-6: DVRd Followed by Ciltacabtagene Autoleucel Versus DVRd Followed by ASCT in Newly Diagnosed Multiple Myeloma | Gordon Cook | Received |
|
|||
| PO-169 | Daratumumab Clinical Trial Analysis: Outcomes in Patients with Lenalidomide-Refractory Relapsed/Refractory Multiple Myeloma, 1-3 Prior LOT | Daniel Zaldumbude | Received |
|
|||
63rd Annual Scientific Meeting of the British Society for Haematology
23 - 25 April 2023, Birmingham
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 23/04/2023 TO 23/04/2024
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 25/04/2023
|
|
